Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
1.520
+0.070 (4.83%)
At close: Mar 31, 2025, 4:00 PM
1.473
-0.047 (-3.11%)
Pre-market: Apr 1, 2025, 5:54 AM EDT
Predictive Oncology Employees
As of December 31, 2023, Predictive Oncology had 35 total employees, including 34 full-time and 1 part-time employees. The number of employees increased by 1 or 2.94% compared to the previous year.
Employees
35
Change (1Y)
1
Growth (1Y)
2.94%
Revenue / Employee
$42,406
Profits / Employee
-$399,147
Market Cap
10.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
POAI News
- 6 days ago - Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary - GlobeNewsWire
- 11 days ago - Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries - GlobeNewsWire
- 5 weeks ago - Predictive Oncology Closes Registered Direct Offering - GlobeNewsWire
- 5 weeks ago - Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing - GlobeNewsWire
- 6 weeks ago - Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform - Business Wire
- 2 months ago - AIRNA Appoints Matthew Hawryluk as Chief Business Officer - Business Wire
- 2 months ago - Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay - GlobeNewsWire
- 2 months ago - PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI - Business Wire